Home NDC 59762-0401-01 NDC 59762-0401-01 - Sucralfate This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 59762-0401
Requested NDC 59762-0401-01
Package NDCs from labels 59762-0401-1, 59762-0401-5, 59762-0401-01
Manufacturer Preferred Pharmaceuticals Inc.
Effective date 2026-09-02
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Sucralfate Tablets Preferred Pharmaceuticals Inc. 2026-09-02 HUMAN PRESCRIPTION DRUG LABEL Sucralfate Tablets REMEDYREPACK INC. 2026-06-11 HUMAN PRESCRIPTION DRUG LABEL Sucralfate - Northwind Health Company, LLC Northwind Health Company, LLC 2026-01-01 HUMAN PRESCRIPTION DRUG LABEL Sucralfate - Bryant Ranch Prepack Bryant Ranch Prepack 2025-06-02 HUMAN PRESCRIPTION DRUG LABEL Sucralfate - Advanced Rx Pharmacy of Tennessee, LLC Advanced Rx Pharmacy of Tennessee, LLC 2024-12-31 HUMAN PRESCRIPTION DRUG LABEL Sucralfate - Redpharm drug Redpharm drug 2024-07-25 HUMAN PRESCRIPTION DRUG LABEL Sucralfate - Advanced Rx Pharmacy of Tennessee, LLC Advanced Rx Pharmacy of Tennessee, LLC 2024-03-13 HUMAN PRESCRIPTION DRUG LABEL Sucralfate - A-S Medication Solutions A-S Medication Solutions 2023-06-29 HUMAN PRESCRIPTION DRUG LABEL Sucralfate - Denton Pharma, Inc. DBA Northwind Pharmaceuticals Denton Pharma, Inc. DBA Northwind Pharmaceuticals 2023-01-01 HUMAN PRESCRIPTION DRUG LABEL Sucralfate Tablets Mylan Pharmaceuticals, Inc. 2020-06-12 HUMAN PRESCRIPTION DRUG LABEL Sucralfate - Denton Pharma, Inc. DBA Northwind Pharmaceuticals Denton Pharma, Inc. DBA Northwind Pharmaceuticals 2020-06-08 HUMAN PRESCRIPTION DRUG LABEL Sucralfate - Aphena Pharma Solutions - Tennessee, LLC Aphena Pharma Solutions - Tennessee, LLC 2019-04-22 HUMAN PRESCRIPTION DRUG LABEL
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59762-0401-1 Sucralfate 100 in 1 BOTTLE TABLET 100 8 59762-0401-5 Sucralfate 500 in 1 BOTTLE TABLET 500 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59762-0401 SUCRALFATE TABLET [GREENSTONE LLC] 7 Current NDC, Legacy NDC, 2 package rows 20241109_ae58c382-c1cf-4ebf-9c97-bdff0682df8b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 4 of 4 · 80 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Sucralfate SUCRALFATE Pacific Pharma, Inc. 7407c58e-766f-4e93-a1bb-c77892ae0174 2024-02-10 Warnings, Adverse reactions Exact identifier unii: XX73205DH5 Sucralfate SUCRALFATE Bryant Ranch Prepack 7b05323d-4695-41d7-8236-1e7b4e8f2a1e 2024-01-11 Adverse reactions Exact identifier rxcui: 314234 unii: XX73205DH5 Sucralfate SUCRALFATE Bryant Ranch Prepack 25ae2ebc-a7e0-4fc9-a8d1-07f7dd7138e5 2024-01-11 Adverse reactions Exact identifier rxcui: 314234 unii: XX73205DH5 Sucralfate SUCRALFATE Proficient Rx LP a42c5f3d-85f1-485b-91e6-58c25b3ddc71 2024-01-01 Adverse reactions Exact identifier rxcui: 314234 unii: XX73205DH5 Sucralfate SUCRALFATE Amneal Pharmaceuticals NY LLC a4f722e7-2885-4f27-8358-9c662439600a 2023-12-30 Adverse reactions Exact identifier rxcui: 314234 unii: XX73205DH5 Anubis Barcelona GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE ANUBIS COSMETICS SL eb651769-4d98-2b3b-e053-2a95a90a36b0 2023-09-01 Warnings Exact identifier unii: H3R47K3TBD Anubis Barcelona Total Hydrating BETAINE, GLYCERIN, POLYSORBATE 20 ANUBIS COSMETICS SL eaefe3b9-9064-18b1-e053-2a95a90a5765 2023-09-01 Warnings Exact identifier unii: H3R47K3TBD Anubis Barcelona New Even LACTIC ACID, CITRIC ACID, GLYCOLIC ACID ANUBIS COSMETICS SL eaeeb6e0-5322-20c4-e053-2995a90a9fd9 2023-09-01 Warnings Exact identifier unii: H3R47K3TBD Sucralfate SUCRALFATE American Health Packaging e4761fb2-6a1a-44de-9d27-f6addabc24c8 2023-08-10 Warnings, Adverse reactions Exact identifier unii: XX73205DH5 Sucralfate SUCRALFATE A-S Medication Solutions 793d033d-d341-4910-8dda-d43d8fd03a4d 2023-06-29 Adverse reactions Exact identifier application number: NDA018333 ndc (package): 50090-5287-0 ndc (product): 50090-5287 rxcui: 314234 spl id: 270e52df-d16b-4a96-b751-ff580c2f00c4 spl set id: 793d033d-d341-4910-8dda-d43d8fd03a4d unii: XX73205DH5 Carafate SUCRALFATE Allergan, Inc. 0fb67b1c-b4c0-46f2-8a81-df1510e006aa 2023-06-08 Warnings, Adverse reactions Exact identifier unii: XX73205DH5 Sucralfate SUCRALFATE Bryant Ranch Prepack 2687d670-8af6-42a2-9081-fee112e80fc0 2023-05-24 Adverse reactions Exact identifier rxcui: 314234 unii: XX73205DH5 Sucralfate SUCRALFATE Bryant Ranch Prepack 370f5ac6-2c64-42ef-ab5d-075a473012f1 2023-05-22 Adverse reactions Exact identifier rxcui: 314234 unii: XX73205DH5 Sucralfate SUCRALFATE A-S Medication Solutions 03b66f88-d346-4260-867c-c942c4c68a79 2023-05-02 Adverse reactions Exact identifier rxcui: 314234 unii: XX73205DH5 f228021b-ad12-8f28-e053-2995a90abd0d a7997846-bd9c-c69a-e053-2995a90a69e2 2023-01-13 Adverse reactions Exact identifier spl set id: a7997846-bd9c-c69a-e053-2995a90a69e2 d101ca0d-ceb8-6d4c-e053-2995a90ac830 a96672be-869e-8a96-e053-2995a90a1c87 2023-01-01 Adverse reactions Exact identifier spl id: d101ca0d-ceb8-6d4c-e053-2995a90ac830 spl set id: a96672be-869e-8a96-e053-2995a90a1c87 Sucralfate SUCRALFATE Aphena Pharma Solutions - Tennessee, LLC b414dc07-681c-4fde-965f-09df64c015e7 2021-05-19 Adverse reactions Exact identifier rxcui: 314234 unii: XX73205DH5 Sucralfate SUCRALFATE Mylan Pharmaceuticals, Inc. ae58c382-c1cf-4ebf-9c97-bdff0682df8b 2020-06-12 Adverse reactions Exact identifier application number: NDA018333 ndc (package): 59762-0401-1 ndc (package): 59762-0401-5 ndc (product): 59762-0401 ndc11 (package): 59762040101 rxcui: 314234 spl id: 311db6f8-1bc9-46af-a866-d7ad4d8193dc spl set id: ae58c382-c1cf-4ebf-9c97-bdff0682df8b unii: XX73205DH5 Sucralfate SUCRALFATE Aphena Pharma Solutions - Tennessee, LLC 84447e21-e311-4e9f-9065-53956e90135c 2019-04-22 Adverse reactions Exact identifier application number: NDA018333 ndc (package): 71610-017-60 ndc (package): 71610-017-94 ndc (package): 71610-017-70 ndc (product): 71610-017 rxcui: 314234 spl id: 8527dc6d-ebec-4ba3-91be-59553b69aef6 spl set id: 84447e21-e311-4e9f-9065-53956e90135c unii: XX73205DH5 Sucralfate SUCRALFATE Teva Pharmaceuticals USA, Inc. c7a43df7-eb37-4273-9250-87953b1fd270 2015-09-01 Adverse reactions Exact identifier rxcui: 314234 unii: XX73205DH5
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.